CALC (STOCKS)
CalciMedica, Inc. Common Stock
$0.657300
+0.037400 (+6.03%)
Prev close: $0.619900
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Rachel Anne Leheny
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $20.59M
- Employees
- 15
- P/E (TTM)
- -0.46
- P/B (TTM)
- 3.46
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
5
Buy
2
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$0.30 | $-0.29 | +0.5856 | +205.04% |
|
Dec 2025 (Q4)
|
$-0.73 | $-0.42 | -0.3092 | -73.48% |
|
Sep 2025 (Q3)
|
$-0.52 | $-0.42 | -0.0992 | -23.57% |
|
Jun 2025 (Q2)
|
$-0.40 | $-0.36 | -0.0430 | -12.04% |
Financial Statements
| Revenues | $0.00 |
| Nonoperating Income/Loss | -$1.61M |
| Operating Expenses | $19.63M |
| Research and Development | $12.55M |
| Other Operating Expenses | $7.08M |
| Operating Income/Loss | -$19.63M |
| Income/Loss From Continuing Operations After Tax | -$21.24M |
| Income/Loss From Continuing Operations Before Tax | -$21.24M |
| Income Tax Expense/Benefit | $0.00 |
| Noninterest Income | $451.00K |
| Net Income/Loss | -$21.24M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$21.24M |
| Net Income/Loss Available To Common Stockholders, Basic | -$21.24M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.37 |
| Diluted Earnings Per Share | -$1.37 |
| Basic Average Shares | 31,817,977 |
| Diluted Average Shares | 31,817,977 |
| Assets | $19.50M |
| Current Assets | $19.46M |
| Cash | $18.60M |
| Other Current Assets | $863.00K |
| Noncurrent Assets | $40.00K |
| Fixed Assets | $36.00K |
| Other Non-current Assets | $4.00K |
| Liabilities | $13.99M |
| Current Liabilities | $3.49M |
| Accounts Payable | $2.07M |
| Other Current Liabilities | $1.42M |
| Noncurrent Liabilities | $10.50M |
| Equity | $5.51M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $5.51M |
| Liabilities And Equity | $19.50M |
| Net Cash Flow From Operating Activities | -$19.11M |
| Net Cash Flow From Operating Activities, Continuing | -$19.11M |
| Net Cash Flow From Investing Activities | $12.20M |
| Net Cash Flow From Investing Activities, Continuing | $12.20M |
| Net Cash Flow From Financing Activities | $19.60M |
| Net Cash Flow From Financing Activities, Continuing | $19.60M |
| Net Cash Flow | $12.70M |
| Net Cash Flow, Continuing | $12.70M |
| Comprehensive Income/Loss | -$21.24M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$21.24M |
| Other Comprehensive Income/Loss | -$7.80M |